The molecular basis of adrenocorticotrophin resistance syndrome

Prog Mol Biol Transl Sci. 2009:88:155-71. doi: 10.1016/S1877-1173(09)88005-8. Epub 2009 Oct 7.

Abstract

Adrenocorticotrophin resistance syndromes comprise familial glucocorticoid deficiency (FGD) and triple A syndrome, which are rare autosomal recessive diseases with distinct clinical features and molecular etiologies. Mutations of melanocortin-2 receptor (MC2R) have been described in segregation with FGD in 25% of patients. More recently melanocortin-2 receptor accessory protein (MRAP), a small single-transmembrane domain protein, was described as an essential protein for the traffic of MC2R and its expression on the plasma membrane. About 20% of FGD patients carry homozygous mutations of MRAP. The ALADIN protein (for alacrima/achalasia/adrenal insufficiency/neurologic disorder) was identified as the molecular basis of triple A syndrome. The elucidation of the genetic basis of the ACTH resistance syndrome has contributed to the better understanding of MC2R function. However, in some patients the molecular etiology is not yet known and awaits further genetic studies.

Publication types

  • Review

MeSH terms

  • Adrenal Insufficiency / complications
  • Adrenal Insufficiency / genetics*
  • Adrenocorticotropic Hormone / metabolism*
  • Esophageal Achalasia / complications
  • Esophageal Achalasia / genetics
  • Glucocorticoids / deficiency
  • Humans
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Receptor, Melanocortin, Type 2 / genetics

Substances

  • Glucocorticoids
  • Membrane Proteins
  • Receptor, Melanocortin, Type 2
  • Adrenocorticotropic Hormone

Supplementary concepts

  • Achalasia Addisonianism Alacrimia syndrome